Cargando…

Human Epidermal Growth Factor Receptor Expression in Colorectal Cancer and Its Relationship with Clinicopathological Characteristics

BACKGROUND Some recent studies reported human epidermal growth factor receptor (HER-2/neu) as a marker that can be used in immunological studies of colorectal carcinoma for predicting the prognosis and the treatment. Therefore, we aimed to investigate the frequency of HER-2 expression in patients wi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Torabizadeh, Zhila, Nosrati, Anahita, Tahvildari, Shadi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Iranian Association of Gastroerterology and Hepatology 2016
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4773079/ https://www.ncbi.nlm.nih.gov/pubmed/26933478 http://dx.doi.org/10.15171/mejdd.2016.03

Ejemplares similares

Evaluation of E-cadherin Expression in Gastric Cancer and Its Correlation with Clinicopathologic Parameters
por: Torabizadeh, Zhila, et al.
Publicado: (2017)

Immunohistochemical Expression of Nanog and Its Relation with Clinicopathologic Characteristics in Breast Ductal Carcinoma
por: Saravi, Omid Emadian, et al.
Publicado: (2019)

Evaluation of epidermal growth factor receptor serum levels and their association with clinicopathological characteristics in patients with colorectal cancer
por: Karabulut, Mehmet, et al.
Publicado: (2017)

Investigating the Relationship between Serum Level of s-Met (Soluble Hepatic Growth Factor Receptor) and Preeclampsia in the First and Second Trimesters of Pregnancy
por: Naghshvar, Farshad, et al.
Publicado: (2013)

The Relationship between Long Noncoding RNA H19 Polymorphism and the Epidermal Growth Factor Receptor Phenotypes on the Clinicopathological Characteristics of Lung Adenocarcinoma
por: Wang, Yao-Chen, et al.
Publicado: (2021)

Evaluation of Antiphospholipid Antibodies in COVID-19 Patients with Coagulopathy
por: Nosrati, Anahita, et al.
Publicado: (2022)

Interleukin-4 receptor and epidermal growth factor receptor expression in colorectal cancer.
por: Kaklamanis, L., et al.
Publicado: (1992)

Evaluation of Human Epidermal Growth Factor Receptor 2 Overexpression, Clinicopathological Characteristics, and Factors Affecting Survival in Gastric Cancer
por: Celayir, Ozde Melisa, et al.
Publicado: (2021)

Human Epidermal Growth Factor Receptor 2 Expression in Unresectable Gastric Cancers: Relationship with CT Characteristics
por: Lee, Jeong Sub, et al.
Publicado: (2017)

Correlation of Hormone Receptor and Human Epidermal Growth Factor Receptor-2/neu Expression in Breast Cancer with Various Clinicopathologic Factors
por: Bansal, Cherry, et al.
Publicado: (2017)

Significance of human epidermal growth factor receptor 2 expression in colorectal cancer
por: TU, JINHUA, et al.
Publicado: (2015)

Higher Expression of Epidermal Growth Factor Receptor Is Associated with Extracellular Matrix Metalloprotease Inducer in Colorectal Adenocarcinoma: Tissue Microarray Analysis of Immunostaining Score with Clinicopathological Parameters
por: Jin, Jong-Shiaw, et al.
Publicado: (2006)

Clinicopathological Characteristics of TZAP Expression in Colorectal Cancers
por: Jung, Soo-Jung, et al.
Publicado: (2020)

Oncogenic fingerprint of epidermal growth factor receptor pathway and emerging epidermal growth factor receptor blockade resistance in colorectal cancer
por: Sobani, Zain A, et al.
Publicado: (2016)

Epidermal growth factor receptor expression in primary cultured human colorectal carcinoma cells.
por: Tong, W. M., et al.
Publicado: (1998)

Transforming growth factor alpha and epidermal growth factor levels in bladder cancer and their relationship to epidermal growth factor receptor.
por: Mellon, J. K., et al.
Publicado: (1996)

Association of Cortactin, Fascin-1 and Epidermal Growth Factor Receptor (EGFR) Expression in Ovarian Carcinomas: Correlation with Clinicopathological Parameters
por: Lin, Chih-kung, et al.
Publicado: (2008)

Epidermal Growth Factor Receptor Mutations in Colorectal Cancer Patients
por: Oh, Bo-Young, et al.
Publicado: (2011)

Impact of LncRNA GAS5 Genetic Variants and the Epidermal Growth Factor Receptor Phenotypes on the Clinicopathological Characteristics of Lung Adenocarcinoma Patients
por: Hsieh, Ming-Hong, et al.
Publicado: (2022)

Targeting Epidermal Growth Factor Receptor (EGFR) in Pediatric Colorectal Cancer
por: De Pasquale, Maria Debora, et al.
Publicado: (2020)

Expression and localization of epidermal growth factor, transforming growth factor-α and epidermal growth factor receptor in the canine testis
por: TAMADA, Hiromichi, et al.
Publicado: (2015)

Evaluation of estrogen receptor expression and its relationship with clinicopathologic findings in gastric cancer
por: Saeidi, Hamid, et al.
Publicado: (2015)

Epidermal Growth Factor Receptor Expression in the Corneal Epithelium
por: Peterson, Joanne L., et al.
Publicado: (2021)

Prognostic and Clinicopathological Significance of Epidermal Growth Factor Receptor (EGFR) Expression in Oral Squamous Cell Carcinoma: Systematic Review and Meta-Analysis
por: Cívico-Ortega, José Luis, et al.
Publicado: (2023)

Fibrinogen/Albumin Ratio (FAR) in Patients with Triple Negative Breast Cancer and Its Relationship with Epidermal Growth Factor Receptor Expression
por: Gao, Wenbo, et al.
Publicado: (2021)

Angiopoietin-2 expression and its relationship with lymphangiogenesis and clinicopathological characteristics in cutaneous malignant melanoma
por: Zheng, Wei, et al.
Publicado: (2023)

Adrenal cortical neoplasms: a study of clinicopathological features related to epidermal growth factor receptor gene status
por: Zhang, Jing, et al.
Publicado: (2014)

Clinicopathologic and prognostic significance of human epidermal growth factor receptor in patients with gastric cancer: An updated meta-analysis
por: Zhang, Zhiqiao, et al.
Publicado: (2017)

Clinicopathological Features and Significance of Epidermal Growth Factor Receptor Mutation in Surgically Resected Early-Stage Lung Adenocarcinoma
por: Lu, Chao-Wen, et al.
Publicado: (2023)

Expression of Epidermal Growth Factor Receptor Detected by Cetuximab Indicates Its Efficacy to Inhibit In Vitro and In Vivo Proliferation of Colorectal Cancer Cells
por: Shigeta, Kohei, et al.
Publicado: (2013)

CT characteristics in pulmonary adenocarcinoma with epidermal growth factor receptor mutation
por: Zhao, Jing, et al.
Publicado: (2017)

The Epidermal Growth Factor Receptor and Its Ligands in Cardiovascular Disease
por: Makki, Nader, et al.
Publicado: (2013)

Association of CD166 expression with clinicopathologic characteristics of colorectal cancer
por: Moslemi, Dariush, et al.
Publicado: (2016)

Expression of transforming growth factor alpha, epidermal growth factor receptor and epidermal growth factor in precursor lesions to gastric carcinoma.
por: Filipe, M. I., et al.
Publicado: (1995)

Relationship between Preoperative (18)F-Fluorodeoxyglucose Uptake and Epidermal Growth Factor Receptor Status in Primary Colorectal Cancer
por: Choi, Yun Jung, et al.
Publicado: (2016)

Molecular determination of epidermal growth factor receptor in normal and neoplastic colorectal mucosa
por: Piazzi, G, et al.
Publicado: (2006)

Epidermal growth factor receptor immunohistochemistry: new opportunities in metastatic colorectal cancer
por: Hutchinson, Ryan A, et al.
Publicado: (2015)

Bladder leiomyoma presenting as uterine pedunculated leiomyoma
por: Nazari, Zeinab, et al.
Publicado: (2022)

Expression of epidermal growth factor receptor, p53, Bcl2, vascular endothelial growth factor, cyclooxygenase-2, cyclin D1, human epidermal receptor-2 and Ki-67: Association with clinicopathological profiles and outcomes in gallbladder carcinoma
por: Doval, Dinesh Chandra, et al.
Publicado: (2014)

Epidermal Growth Factor Receptor Expression in Esophageal Adenocarcinoma: Relationship with Tumor Stage and Survival after Esophagectomy
por: Navarini, Daniel, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_71jb1mg8hfsj3ieir63p3mqc16